Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

TPST

Live52w low +48.3%

Core line items from TPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: Tempest Therapeutics, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2017 2017-12-31	Annual 2016 2016-12-31	Annual 2015 2015-12-31	Annual 2014 2014-12-31
Revenue	$295.00K	$653.00K	$277.00K	$0.00
Operating Income	$-84.33M	$-81.01M	$-72.00M	$-47.93M
Net Income	$-84.58M	$-82.26M	$-73.22M	$-49.52M
EPS (Diluted)	Not available	Not available	Not available	Not available
Total Assets	$19.81M	$122.54M	$138.61M	$65.57M
Total Liabilities	$4.83M	$14.32M	$11.76M	$10.25M
Cash & Equivalents	$17.58M	$43.93M	$43.22M	$6.41M
Free Cash Flow OCF − CapEx	$-20.34M	$-64.32M	$-55.52M	$-33.39M
Shares Outstanding	246.35K	35.64M	27.30M	24.08M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from TPST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +48.3%

Entity: Tempest Therapeutics, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2017 2017-12-31	Annual 2016 2016-12-31	Annual 2015 2015-12-31	Annual 2014 2014-12-31
Revenue	$295.00K	$653.00K	$277.00K	$0.00
Operating Income	$-84.33M	$-81.01M	$-72.00M	$-47.93M
Net Income	$-84.58M	$-82.26M	$-73.22M	$-49.52M
EPS (Diluted)	Not available	Not available	Not available	Not available
Total Assets	$19.81M	$122.54M	$138.61M	$65.57M
Total Liabilities	$4.83M	$14.32M	$11.76M	$10.25M
Cash & Equivalents	$17.58M	$43.93M	$43.22M	$6.41M
Free Cash Flow OCF − CapEx	$-20.34M	$-64.32M	$-55.52M	$-33.39M
Shares Outstanding	246.35K	35.64M	27.30M	24.08M

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.